Clinical Trials Logo

Clinical Trial Summary

In kidney transplantation, donor selection is based in part on the assessment of the functional capacity of the kidneys. For this purpose, it is recommended to measure the glomerular filtration rate (GFR) by a reference technique. To estimate GFR, several approaches are possible depending on the type of measurement (urinary or plasma) and the marker (exogenous or endogenous) used. Among these methods, the measurement of inulin clearance has long been considered the reference method. The occurrence of anaphylactic reactions led to its withdrawal from the market. Iohexol, an iodinated contrast agent, has characteristics similar to inulin. It is eliminated by glomerular filtration and its biological determination is simple. Nevertheless, the techniques currently used to calculate plasma clearance of Iohexol have been imperfectly validated and are not always easy to implement in practice. the investigators propose to develop a Bayesian estimator for estimating Iohexol clearance applied to a population of healthy subjects, representative of potential kidney donors.


Clinical Trial Description

n/a


Study Design


NCT number NCT05136963
Study type Interventional
Source Centre Hospitalier Universitaire de Saint Etienne
Contact Christophe MARIAT, MD PhD
Phone (0)477828739
Email christophe.mariat@chu-st-etienne.fr
Status Not yet recruiting
Phase Phase 1
Start date June 2024
Completion date April 2025